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612a Wednesday, February 6, 2013Phospholipase C-b (PLC-b) catalyzes the hydrolysis of the plasma membrane
(PM) lipid phosphatidylinositol-(4,5)-bisphosphate (PI(4,5)P2), thereby reduc-
ing the PM concentration of its precursor PI(4)P. A recent report proposed in-
dependent PI(4,5)P2 and PI(4)P PM pools with essential physiological
functions, but it remains unknown whether PLC-b targets to these pools
differentially.
Here, we investigated the time course and specificity of PLC-b-dependent
phospholipid depletion in living CHO cells using genetically-encoded phos-
pholipid sensors, total internal reflection fluorescence microscopy and whole
cell patch clamp. PLC-b mediated PI(4,5)P2 hydrolysis was detected reliably
using KCNQ (Kv7)-mediated Kþ currents, the PI(4,5)P2 reporters PLCd1-PH
and Epsin ENTH, but not with the C-terminus of Tubby protein. Analogous ex-
periments showed that activation of PLC-b did not reduce the concentration of
PI(4) detected with the PI(4)P-specific reporter Osbp-PH. When PLC-b3 was
heterologously overexpressed, Tubby-Cterm and Osbp-PH reported on the
PLC-b-induced changes of PI(4,5)P2 and PI(4)P, respectively.
In summary, we present detailed real-time analysis of PLC-b activity in living
cells. Our findings indicate that phospholipid sensors may detect different phos-
pholipid pools that are accessible to PLC-b differentially. Hence, this work sup-
ports the presence of functional phospholipid pools in living cells.
This work was supported by Deutsche Forschungsgemeinschaft through SFB
593 (TP A12) to D.O.
3149-Pos Board B304
Regulation of CAMP Compartmentation by Membrane Microdomains
Shailesh R. Agarwal1, Monica Rice1, Cherie A. Singer1,
Viacheslav Nikolaev2, Martin Lohse2, Robert D. Harvey1.
1University of Nevada, Reno, NV, USA, 2University of Wurzburg,
Wurzburg, Germany.
The role of different membrane domains in the compartmentation of cAMP sig-
naling was investigated using the FRET-based biosensor Epac2-camps. The
MyrPalm sequence from Lyn kinase and the CAAX sequence from Rho
GTPase were used to target this probe to lipid raft (Epac2-MyrPalm) or non-
lipid raft (Epac2-CAAX) domains, respectively. Confocal imaging established
that both probes were targeted to the plasma membrane in HEK293 cells. FRAP
analysis demonstrated that depletion of membrane cholesterol altered both the
recovery half-time and the mobile fraction of Epac2-MyrPalm but not Epac2-
CAAX, confirming that each probe was targeted to the correct microdomain.
FRET responses of these probes were then used to monitor relative changes
in cAMP activity associated with lipid raft and non-raft domains. The results
demonstrated that basal cAMP activity is significantly higher in non-raft do-
mains. This was supported by the fact that the maximal increase in cAMP
over baseline following agonist stimulation was significantly smaller for
Epac2-CAAX than it was for Epac2-MyrPalm, consistent with the idea that
the probe was partially activated by a higher basal level of cAMP associated
with non-lipid raft domains. In addition, inhibition of adenylyl cyclase activity
with MDL 12330A reduced basal cAMP activity detected by Epac2-CAAX but
not Epac2-MyrPalm. Responses detected by Epac2-CAAXwere also more sen-
sitive to direct activation of adenylyl cyclase by forskolin, but less sensitive to
inhibition of type 4 phosphodiesterase activity by rolipram. These results indi-
cate that there are diffusionally-restricted pools of cAMP associated with dif-
ferent membrane microdomains under basal conditions. The higher basal
cAMP activity associated with non-lipid raft domains can be explained by dif-
ferences in basal adenylyl cyclase and phosphodiesterase activity.
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A central, but still unresolved question regarding the function of integrins is
how these adhesion receptors regulate both their conformation and dynamic
nanoscale organization on the membrane to generate adhesion-competent
microclusters upon ligand binding. By superresolution nanoscopy, we recently
showed that in quiescent monocytes, LFA-1 preorganizes in ligand-
independent nanoclusters proximal to nanoscale raft components (1,2). Further-
more, to dissect the relationship between conformational state, lateral mobility,
and microclustering we exploited the high spatial (nanometer) accuracy and
temporal resolution of single dye tracking and found that LFA-1 nanoclusters
are primarily mobile on the cell surface with a small (ca. 5%) subset of
conformational-active LFA-1 nanoclusters preanchored to the cytoskeleton (3).Lateral mobility resulted crucial for the formation of microclusters upon ligand
binding and for stable adhesion under shear flow. Ongoing investigation in our
laboratory points towards the importance of a specific lipid composition of the
membrane nano-environment in modulating LFA-1 biophysical properties
which eventually regulate the onset of leukocyte adhesion. Since several (pa-
tho)physiological stimuli can alter either temporarily or permanently the
plasma membrane lipid composition, our studies offer a novel framework to
understand integrin regulation via the lipid nanoenvironment.
(1) Van Zanten et al PNAS 2009.
(2) Van Zanten et al PNAS 2010.
(3) Bakker et al PNAS 2012.
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The ghrelin receptor (GhR) is a class A G protein-coupled receptor (GPCR)
involved in the entero-endocrine signaling systems that regulates food intake
and energy homeostasis. The GhR is noted for its unusually high basal con-
stitutively activity. GhR is a potential drug target for ‘‘diabesity’’ syndromes,
and the interaction between GhR and its endogenous peptide ligand, ghrelin,
has been intensively studied. However, there is only a limited understanding
of GhR pharmacology and its molecular mechanism of signal transduction.
Using well-established amber codon suppression technology and state-of-
the-art single-molecule techniques, we are developing tools to monitor
directly differential conformational dynamics of GhR in the presence and ab-
sence of its binding partners, including ligands, G proteins, or other GPCRs.
For example, we are preparing single-site and double-site fluorescently
labeled GhR and a series of labeled ghrelin analogues. These engineered re-
ceptors can be studied in cell-based systems or reconstituted in NABBs
(Nanoscale Apolipoprotein Bound Bilayers) after purification. These types
of approaches will enable us to better understand the complexity of GhR sig-
naling in the neuro-endocrine system, providing insights to design specific
drugs for targeting fine-tuned signal pathways involved in metabolic disor-
ders like obesity and diabetes.
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Transforming growth factor-b (TGF-b) and bone morphogenetic protein
(BMP) signal via two Ser-Thr kinase receptors, type I type II (TbRI and II,
BMPRI and II for the TGF-b and BMP receptors, respectively), which appear
at the cell surface as monomers, homomeric and heteromeric complexes. their
extracellular domains (EDs) complexed with ligands were shown to form het-
erotetramers. However, the interaction dynamics among the full-length recep-
tors in live cell membranes, the domains involved, and the potential roles of
receptor homodimerization were largely unexplored. Using patch/FRAP and
computerized immunofluorescence co-patching of epitope-tagged receptors
[wild-type (wt) or mutants] in live cells, we show that the oligomerizaiton dy-
namics are distinctly different for the two receptor systems. For TGF-b recep-
tors, we find clear differences between TbRII and TbRI oligomeric
interactions: (1) the homodimerization of TbRII, but not TbRI, depends on a cy-
toplasmic juxtamembrane region; and (2) TbRI/TbRII hetero-oligomerization
depends on the cytoplasmic domain of TbRI and on a C-terminal region of
TbRII, distinct from the region involved in TbRII homodimerization. TGF-
b1 binding mildly elevated TbRII homodimerization, and strongly enhanced
TbRI/TbRII heteromeric complex formation. Notably, both homomeric and
heteromeric TGF-b receptor complexes were stable on the patch/FRAP time-
scale (minutes).
In contrast, the BMP receptors display stable interactions on the same timescale
only for homomeric complexes, while the heterocomplexes are transient. Inter-
estingly, the BMPR heterocmplexes appear to form at the expense of homo-
dimers, and stabilization of BMPRII/BMPRIb heteromeric (but not
homomeric) complexes by IgG binding elevates phospho-Smad formation
both without and with BMP-2. Based on these findings, we propose two mech-
anisms that can suppress the tendency of preformed BMP receptor hetero-
oligomers to signal without ligand.
